11.JPG)
Global Biospecimen Contract Research Services Market Size is valued at USD 5.0 Billion in 2024 and is predicted to reach USD 17.7 billion by the year 2034 at a 13.6% CAGR during the forecast period for 2025-2034.
Increased investment in pharmaceutical R&D, an increase in the number of clinical trials, and the high cost of in-house drug development are driving growth in the Biospecimen Contract Research Services Market (encouraging pharma-biotech companies to outsource). Growth in the drugs and biologics market despite the COVID-19 pandemic, rising demand for specialized testing services among end-users, and the need for novel clinical trial designs for complex cell and gene therapies are all expected to provide a wide range of growth opportunities for market participants.
Most pharmaceutical, biopharmaceutical, and medical device companies continue to invest heavily in developing new drugs and devices. In the pharmaceutical industry, R&D is essential, and pharmaceutical firms invest in research and development to bring high-quality, innovative products to market. The increased investment in biologics and biosimilars by biopharmaceutical companies is attributed to an increase in the number of approved products globally. Biologics like proteins, peptides, and monoclonal antibodies currently account for more than half of all drug candidates in the discovery stage.
The Biospecimen Contract Research Services market is segmented into the biospecimen types and therapeutics areas. Based on the type of biospecimen types, the market is segmented into oncological and non-oncological studies. The oncological studies are further segmented into FFPE Tissue, Frozen Tissue, Plasma / Serum and Other Biospecimens. The non-oncological studies are further segmented into Blood Products, Human Tissue and Other Biospecimens. The therapeutics area segment includes Oncological Disorders, Neurological Disorders, Cardiovascular Disorders and Other Therapeutic Areas.
The oncological studies segment is accounted as a significant contributor in the Biospecimen Contract Research Services market. The demand for biospecimens in cancer research has increased, but there is little data on biospecimen usage trends. These data are required to forecast future demand. This was due to larger cohort sizes for both frozen and FFPE tissues. For decades, Formalin-Fixed Paraffin-Embedded (FFPE) tissue specimens have been a mainstay of research and therapeutic applications. FFPE is a type of biopsy specimen preservation and preparation that aids in the examination, experimental research, and diagnostic/drug development. To preserve the proteins and vital structures within the tissue, a tissue sample is first fixed in formaldehyde, also known as formalin. It is then embedded in a paraffin wax block, making it easier to cut slices of the required sizes for examination on a microscopic slide.
Oncology, or the study of cancer and tumours, has made significant advancements in the prevention, treatment, and prognosis of many childhood cancers. Despite this progress, cancer remains the leading cause of death in children. Childhood cancer differs from adult cancers in terms of development, treatment, response to therapy, therapy tolerance, and prognosis. In most cases, childhood cancer responds better to treatment, the child can tolerate more aggressive treatment, and the forecast is better.
North America dominated the global biospecimen contract research services market. North America's dominance in this market is primarily due to the market's rapid growth, pharmaceutical and biopharmaceutical companies' increased focus on outsourcing, and an increase in the number of clinical trial activities in the region. The rising popularity of precision/personalized medicine and genetic testing has been a major driving force in the region's market. Biobanks have long been essential in biomedical research. Over the last few decades, there have been several advancements in the platforms and tools used in genetic studies. This has resulted in increased clinical lab demand for biospecimens to develop assays for genetic testing in this region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 5.0 billion |
|
Revenue Forecast In 2034 |
USD 17.7 billion |
|
Growth Rate CAGR |
CAGR of 13.6 % from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Biospecimen Type, By Therapeutic Area |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; India; Japan; Brazil; Mexico ; France; Italy; Spain; China; South Korea; South East Asia |
|
Competitive Landscape |
BioChain Institute, BioIVT, Boca Biolistics, Creative Bioarray, Cureline, Discovery Life Sciences, Infinity BiologiX, Precision for Medicine, Inc., PrecisionMed, Inc., Medicover, National BioService, ICON plc, The MT Group, Eolas Biosciences Co. Ltd, Indivumed GmbH, Ardent Clinical Research Services, Capital Biosciences, Inc., GR BioResearch, REPROCELL, Trans-Hit Bio (Azenta US, Inc.) and iSpecimen |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biospecimen Contract Research Services Market Snapshot
Chapter 4. Global Biospecimen Contract Research Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 2: By Biospecimen Types Estimates & Trend Analysis
5.1. By Biospecimen Types & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Biospecimen Types:
5.2.1. Oncological Studies
5.2.1.1. FFPE Tissue
5.2.1.2. Frozen Tissue
5.2.1.3. Plasma / Serum
5.2.1.4. Other Biospecimens
5.2.2. Non-Oncological Studies
5.2.2.1. Blood Products
5.2.2.2. Human Tissue
5.2.2.3. Other Biospecimens
Chapter 6. Market Segmentation 3: By Therapeutic Area Estimates & Trend Analysis
6.1. By Therapeutic Area & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
6.2.1. Oncological Disorders
6.2.2. Neurological Disorders
6.2.3. Cardiovascular Disorders
6.2.4. Other Therapeutic Areas
Chapter 7. Biospecimen Contract Research Services Market Segmentation 4: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Biospecimen Contract Research Services Market revenue (US$ Million) estimates and forecasts By Biospecimen Types, 2021-2034
7.1.2. North America Biospecimen Contract Research Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
7.1.3. North America Biospecimen Contract Research Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Biospecimen Contract Research Services Market revenue (US$ Million) By Biospecimen Types, 2021-2034
7.2.2. Europe Biospecimen Contract Research Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
7.2.3. Europe Biospecimen Contract Research Services Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Biospecimen Contract Research Services Market revenue (US$ Million) By Biospecimen Types, 2021-2034
7.3.2. Asia Pacific Biospecimen Contract Research Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
7.3.3. Asia Pacific Biospecimen Contract Research Services Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Biospecimen Contract Research Services Market revenue (US$ Million) By Biospecimen Types, 2021-2034
7.4.2. Latin America Biospecimen Contract Research Services Market revenue (US$ Million) By Therapeutic Area, 2021-2034
7.4.3. Latin America Biospecimen Contract Research Services Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Biospecimen Contract Research Services Market revenue (US$ Million) By Biospecimen Types, 2021-2034
7.5.2. Middle East & Africa Biospecimen Contract Research Services Market revenue 2021-2031 By Therapeutic Area, 2021-2034
7.5.3. Middle East & Africa Biospecimen Contract Research Services Market revenue2021-2031 by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. BioChain Institute
8.2.2. BioIVT
8.2.3. Boca Biolistics
8.2.4. Creative Bioarray
8.2.5. Cureline
8.2.6. Discovery Life Sciences
8.2.7. Infinity BiologiX
8.2.8. Precision for Medicine, Inc.
8.2.9. PrecisionMed, Inc.
8.2.10. Medicover
8.2.11. National BioService
8.2.12. ICON plc
8.2.13. The MT Group
8.2.14. Eolas Biosciences Co. Ltd
8.2.15. Indivumed GmbH
8.2.16. Ardent Clinical Research Services
8.2.17. Capital Biosciences, Inc.
8.2.18. GR BioResearch
8.2.19. REPROCELL
8.2.20. Trans-Hit Bio ( Azenta US, Inc.)
8.2.21. iSpecimen
8.2.22. Fidelis
8.2.23. GENETICIST INC
8.2.24. BIOMEDICA CRO
8.2.25. Circuit Clinical
8.2.26. Other Prominent Players
By Service Type
By Specimen Type
By Therapeutic Area
By End-User
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
